Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

NCT06725693 is registered in ClinicalTrials.gov with Tianjin Medical University as lead sponsor.

NCT NCT06725693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06725693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
Lead sponsor
Tianjin Medical University
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2019
Completion date
November 1, 2027
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

glp1-r-related disease, insulinoma, positron emission tomography, tumor